HOXB13 and prostate carcinoma: Previous studies show colocalization of TFs FOXA1 and HOXB13 at the reprogrammed AR binding sites in human prostate cancer cells and draw a link between TMPRSS2-ERG fusion and co-option of FOXA1 and HOXB13 to specific regulatory elements across the genome85.